China’s beating the US in neuroscience:
“There is a very real possibility that without significant regulatory reform, if you’re a wealthy American, in 10 years, the only place you’ll be able to get your state-of-the-art cancer care is in Shanghai,” said Max Hodak, former president of Neuralink.
“This is going to be one of the three or four major plot lines of the next decade,” former Neuralink president says.
